aerosolized vancomycin or gentamicin
Phase 2Completed 0 watching 0 views this week⚡ Active
47
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Ventilator Associated Pneumonia
Conditions
Ventilator Associated Pneumonia, Respiratory Infection, Tracheobronchitis
Trial Timeline
Aug 1, 2003 → Sep 1, 2004
NCT ID
NCT00396578About aerosolized vancomycin or gentamicin
aerosolized vancomycin or gentamicin is a phase 2 stage product being developed by Nektar Therapeutics for Ventilator Associated Pneumonia. The current trial status is completed. This product is registered under clinical trial identifier NCT00396578. Target conditions include Ventilator Associated Pneumonia, Respiratory Infection, Tracheobronchitis.
Hype Score Breakdown
Clinical
17
Activity
12
Company
5
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00396578 | Phase 2 | Completed |
Competing Products
9 competing products in Ventilator Associated Pneumonia
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Doripenem + Imipenem-Cilastatin + Placebo | Johnson & Johnson | Phase 3 | 77 |
| Imipenem/cilastatin + Imipenem/cilastatin + Doripenem + Doripenem | Johnson & Johnson | Phase 2 | 52 |
| Ceftolozane/Tazobactam + Piperacillin/Tazobactam | Merck | Phase 3 | 77 |
| Imipenem + Imipenem | Merck | Approved | 85 |
| Vancomycin + Linezolid | Pfizer | Approved | 84 |
| anidulafungin | Pfizer | Phase 2 | 51 |
| Linezolid | Pfizer | Pre-clinical | 22 |
| IC43 + Placebo | Valneva SE | Phase 2 | 47 |
| Ceftobiprole | Basilea Pharmaceutica | Phase 1 | 28 |
Other Products from Nektar Therapeutics
NKTR-102 + Eribulin + Ixabepilone + Vinorelbine + Gemcitabine + Paclitaxel + Docetaxel + Nab-paclitaxelPhase 3
72
NKTR-181 BID tablets + Placebo to match NKTR-181 BID tabletsPhase 3
72
NKTR-102 + Treatment of Physician's Choice (TPC)Phase 3
72
NKTR-181 BID tabletsPhase 3
72
NKTR-255 at 1.5 µg/kg + NKTR-255 at 3.0 μg/kg + NKTR-255 at 3.0/6.0 μg/kgPhase 2/3
60